Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Obesity and Diabetes
Study results from Institute of Biomolecular Chemistry provide new insights into obesity and diabetes
December 10th, 2007
Research findings, 'Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells,' are discussed in a new report. "The endocannabinoid, arachidonoylethanolamide (AEA), and the peroxisome proliferator-activated receptor (PPAR)-alpha ligand, oleylethanolamide (OEA) produce opposite effects on lipogenesis. The regulation of OEA and its anti-inflammatory congener, palmitoylethanolamide (PEA), in adipocytes and pancreatic beta-cells has not been investigated," researchers in Naples, Italy report. "We report here the results of studies on acylethanolamide regulation in these cells during obesity and hyperglycaemia, and provide an overview of...
Source: Obesity & Diabetes Week (2007-12-10)
|
